Inhibition of azoxymethane-induced aberrant crypt foci in rat by diphenylmethyl selenocyanate through downregulation of COX-2 and modulation of glutathione-S-transferase and lipid peroxidation

Biological Trace Element Research

Volumn 105, Issue 1-3, 2005, Pages 171-185

  Ghosh, Samit ^a   Das, Rajat Kumar ^a   Sengupta, Archana ^a   Bhattacharya, Sudin ^a  

^a Chittaranajan National Cancer Institute   (India)

Author keywords

Aberrant crypt foci; Colon carcinogenesis; Cyclooxygenase 2; Diphenylmethylselenocyanate; Glutathione S transferase; Lipid peroxidation

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2; DIPHENYLMETHYLSELENOCYANATE; GLUTATHIONE TRANSFERASE; ORGANOSELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ABERRANT INTESTINE CRYPT FOCI; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; PRECANCER; PROTEIN EXPRESSION; RAT;

ANIMALS; AZOXYMETHANE; BLOTTING, WESTERN; COLON; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUTATHIONE TRANSFERASE; LIPID PEROXIDATION; LIVER; MALE; MODELS, CHEMICAL; NEOPLASMS, EXPERIMENTAL; ORGANOSELENIUM COMPOUNDS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; TIME FACTORS;

EID: 22444447436     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:105:1-3:171     Document Type: Article

References (42)

1. R. J. Jass, Lower gastrointestinal tract, in The Cancer Handbook, M. Alison, ed., Nature Publication Group, pp. 543-561 (2002).
2. I. Dove-Edwin and H. J. Thomas, The prevention of colorectal cancer, Aliment. Pharmacol. Therap. 15(3), 323-336 (2001).
3. American Cancer Society, Cancer Facts and Figures, American Cancer Society, Washington, DC, p. 10 (2003).
4. II expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis, Carcinogenesis 21, 1513-1519 (2000).
5. K. Sieja and M. Talerczyk, Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy, Gynecol. Oncol. 93, 320-327 (2004).
6. K. El-Bayoumy The role of selenium in cancer prevention, in Cancer Prevention, V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg, eds., J. B. Lippincott, Philadelphia, pp. 1-15 (1991).
7. K. El-Bayoumy, P. Upadhyaya, Y. H. Chae, et al., Chemoprevention of cancer by organoselenium compounds, J. Cell Biochem. 225, 92-100 (1995).
8. J. R. Nayim, S. Sugie, K. El-Bayoumy, et al., Effect of dietary benzylselenocyanate on azoxymethane-induced colon carcinogenesis in male F344 rats, Nutr. Cancer 15, 129-139 (1991).
9. R. P. Bird, Role of aberrant crypt foci in understanding the pathogenesis of colon cancer, Cancer Lett. 93, 55-71 (1995).
10. T. P. Pretlow, B. J. Barrow, W. S. Ashton, et al., Aberrant crypts: putative preneoplastic foci in human colonic mucosa, Cancer Res. 51, 1564-1567 (1991).
11. S. Ghosh, R. K. Das, A. Sengupta, et al., Induction of apoptosis and inhibition of cell proliferation by diphenylmethyl selenocyanate during azoxymethane induced rat colon carcinogenesis, Int. J. Cancer Prev. 5, in press (2005).
12. J. I. Wilkinson and M. L. Clapper, Detoxification enzymes and chemoprevention, Proc. Soc. Exp. Biol. Med. 216, 192-200 (1997).
13. L. J. Marnett, Oxyradicals and DNA damage, Carcinogenesis (Lond.) 21, 361-370 (2000).
14. V. Ledinghen, H. Liu, F. Zhang, et al., Induction of cyclooxygenase-2 by tumour promoters in transformed P4502E1-expressing hepatocytes, Carcinogenesis 23(1), 73-79 (2002).
15. M. Takahashi, M. Mutoh, T. Kawamori, et al., Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis, Carcinogenesis 21(7), 1319-1327 (2000).
16. T. E. Crew, D. J. E. Elder, and C. Paraskeva, A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate, Carcinogenesis 21(1), 69-77 (2000).
17. H. Sawaoka, S. Tsuji, M. Tsuji, et al., Involvment of cyclooxygenase 2 in proliferation and morphogenesis induced by transforming growth factor alpha in gastric epithelial cells, Prostagland Leukotriene Essent. Fatty Acids 61, 315-322 (1999).
18. D. A. Khujubu, D. S. Fletcher, B. C. Varnum, et al., TIS10, a phorbol ester tumour promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue, J. Biol. Chem. 266, 12,866-12,872 (1991).
19. R. N. Dubois, J. Awad, J. Morrow, et al., Regulation of eicosonide production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester, J. Clin. Invest. 93, 493-498 (1994).
20. D. A. Jones, D. P. Carlton, T. M. McIntyre, et al., Molecular cloning of human prostaglandin synthase type II demonstration of expression in response to cytokines, J. Biol. Chem. 268, 9049-9054 (1993).
21. N. Yoshimi, M. Shimizu, K. Matsunaga, et al., Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane, Jpn. J. Cancer Res. 90, 406-412 (1999).
22. T. Tanaka, H. Kohno, R. Shimada, et al., Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats, Carcinogenesis 21, 1183-1189 (2000).
23. C. T. H. Pederson, Preparation of some 4-substituted selenosemicarbazides, Acta Chem. Scand. 17, 1459-1461 (1963).
24. D. Dhawan, S. Balasubramanian, A. J. Amonkar, et al., Chemopreventive effect of 4′-dimethyl epipodophyllotoxin on DMBA/TPA induced mouse skin carcinogenesis, Carcinogenesis 20, 997-1003 (1999).
25. E. A. McLellan, A. Medline, and R. P. Bird, Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions, Cancer Res. 51, 5270-5274 (1991).
26. W. H. Habig, M. J. Pabst, and W. B. Jakoby, Glutathione S-transferase, J. Biol. Chem. 249, 7130-7139 (1974).
27. H. Okawa, N. Oshisi, and K. Yagi. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Ann. Biochem. 95, 351-358 (1979).
28. O. H. Lowry, N. J. Rosebrough, A. L. Farr, et al., Protein measurement with Folin Phenol Reagent, J. Biol. Chem. 193, 265-275 (1951).
29. 4, Nature (Lond.) 227, 680-685 (1970).
30. J. Singh, R. Hamid, and B. S. Reddy, Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post initiation stage of colon carcinogenesis, Cancer Res. 57, 3465-3470 (1997).
31. J. H. Weisberger, A. Rivenson, J. Reinhardt, et al., Effect of black tea on azoxymethane-induced colon cancer, Carcinogenesis 19(1), 229-232 (1998).
32. O. S. Sohn, H. Ishizaki, C. S. Yang, et al., Metabolism of azoxymethane, methylazoxymethanol and N-nitrosodimethylamine by cytochrome P450IIE1, Carcinogenesis 12, 127-131 (1991).
33. P. Talalay Chemical protection against cancer by induction of electrophile detoxification (phase II) enzymes, in Cellular and Molecular Targets for Chemoprevention. V. E. Steele, et al. CRC, Boca Raton, FL, pp. 193-205 (1992).
34. R. A. Sharma, M. M. Manson, A. Gescher, et al., Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents, Eur. J. Cancer 37, 12-22 (2001).
35. L. J. Marnett, Lipid peroxidation-DNA damage by malondialdehyde, Mutat. Res. 424, 83-95 (1999).
36. C. V. Rao, C. Q. Wang, B. Simi, et. al. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene) selenocyanate, a novel organoselenium compound with low toxicity Cancer Res. 61, 3647-3652 (2001).
37. C. G. Fraga and A. L. Tappel, Damage to DNA concurrent with lipid peroxidation in rat liver slices, Biochem. J. 252, 893-896 (1988).
38. W. L. Smith, R. M. Garavito, and D. L. DeWitt, Prostaglandin endoperoxide H synthase (cyclooxygenases)-1 and 2, J. Biol. Chem. 271, 33,157-33,160 (1996).
39. J. Singh, R. Hamid, and B. S. Reddy, Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post initiation stage of colon carcinogenesis, Cancer Res. 57, 3465-3470 (1997).
40. R. A. Sharma, A. Gescher, and J. P. Plastaras, Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells, Carcinogenesis 22(9), 1557-1560 (2001).
41. G. J. Kelloff, Intervention and chemoprevention of cancer, in The Cancer Handbook, M. Alison, ed., Nature Publication Group, pp. 435-457 (2002).
42. L. J. Marnett, A. K. Basu, S. M. O'Hara, et al., Reaction of malondialdehyde with guanine nucleosides: formation of adducts containing oxadrazabicyclononene residues in the base pairing regions, J. Am. Chem. Soc. 108, 1348-1350 (1986).